These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36340453)

  • 1. Circulating miRNA Expression Profiling in Breast Cancer Molecular Subtypes: Applying Machine Learning Analysis in Bioinformatics.
    Triantafyllou A; Dovrolis N; Zografos E; Theodoropoulos C; Zografos GC; Michalopoulos NV; Gazouli M
    Cancer Diagn Progn; 2022; 2(6):739-749. PubMed ID: 36340453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer.
    Pliakou E; Lampropoulou DI; Dovrolis N; Chrysikos D; Filippou D; Papadimitriou C; Vezakis A; Aravantinos G; Gazouli M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of breast cancer molecular classification by miRNA expression profiles.
    Søkilde R; Persson H; Ehinger A; Pirona AC; Fernö M; Hegardt C; Larsson C; Loman N; Malmberg M; Rydén L; Saal L; Borg Å; Vallon-Christerson J; Rovira C
    BMC Genomics; 2019 Jun; 20(1):503. PubMed ID: 31208318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
    Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
    OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
    Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
    Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of circulating microRNA signatures for breast cancer detection.
    Chan M; Liaw CS; Ji SM; Tan HH; Wong CY; Thike AA; Tan PH; Ho GH; Lee AS
    Clin Cancer Res; 2013 Aug; 19(16):4477-87. PubMed ID: 23797906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated microRNA clusters in response to retinoic acid and CYP26B1 inhibitor induced testicular function in dogs.
    Kasimanickam VR; Kasimanickam RK; Dernell WS
    PLoS One; 2014; 9(6):e99433. PubMed ID: 24911586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
    Beheshti A; Stevenson K; Vanderburg C; Ravi D; McDonald JT; Christie AL; Shigemori K; Jester H; Weinstock DM; Evens AM
    Sci Rep; 2019 Nov; 9(1):17161. PubMed ID: 31748664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Potential of MiR-379/656 MicroRNA Cluster in Molecular Subtypes of Breast Cancer.
    Lal M; Ansari AH; Agrawal A; Mukhopadhyay A
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.
    Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W
    Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
    BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.